This is webinar 2 of 3 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this webinar, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Janese Laster and Barham Abu Dayyeh to discuss:
- Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastrointestinal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer.
- Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.
- Updates on medications and devices for obesity management that are available now and a look into what may be available in the future.
Register
Learning Objectives
- Discuss the spectrum of therapeutic and surgical options for obesity treatment, including new and emerging strategies.
- Develop personalized obesity treatment plans with patients through shared decision making, encompassing multidisciplinary care.
Faculty
Andres Acosta, MD, PhD, Course Director, Co-host
Assistant Professor of Medicine
Consultant, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Octavia Pickett-Blakely, MD, MHS, Co-host
Associate Professor of Clinical Medicine
Director, GI Nutrition, Celiac Spue and Obesity Program
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania
Janese Laster, MD
Owner, Gut Theory: Total Digestive Care
Washington, District of Columbia
Barham Abu Dayyeh, MD, MPH
Professor of Medicine
Consultant, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Pricing
Member
|
Nonmember
|
$Free |
$Free |
Accreditation Statement
The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: June 14, 2023
Disclosures
Andres Acosta
Amgen: Consulting
Gila Therapeutics: Stock Shareholder
Phenomix Sciences: Stock Shareholder
Octavia Pickett-Blakely
Nothing to disclose
Janese Laster
Nothing to disclose
Barham Abu Dayyeh
Coming soon